$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical composition for treatment of Duchenne muscular dystrophy 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-021/04
  • C12Q-001/68
  • C12P-019/34
출원번호 US-0930251 (2001-08-16)
우선권정보 JP-0256547 (2000-08-25)
발명자 / 주소
  • Matsuo, Masafumi
  • Kamei, Shoichiro
출원인 / 주소
  • JCR Pharmaceuticals Co., Ltd., Matsuo
대리인 / 주소
    Greenblum & Bernstein, P.L.C.
인용정보 피인용 횟수 : 66  인용 특허 : 7

초록

The invention provides an isolated and purified DNA set forth as SEQ ID NO:15 in the Sequence Listing and an antisense oligonucleotide complementary to the DNA. The DNA represents the splicing enhancer sequence (SES) in exon 45 of human dystrophin gene, and serves as a template in preparation of the

대표청구항

1. An isolated and purified oligonucleotide selected from the group consisting of: a DNA consisting of a nucleotide sequence set forth as SEQ ID NO:15 in the Sequence Listing, andan RNA consisting of a nucleotide sequence set forth as SEQ ID NO:15 in the Sequence Listing in which all thymine nucleot

이 특허에 인용된 특허 (7)

  1. Baker Brenda F. ; Cowsert Lex M., Antisense inhibition of Elk-1 expression.
  2. Kole Ryszard (Chapel Hill NC) Dominski Zbigniew (Chapel Hill NC), Antisense oligonucleotides which combat aberrant splicing and methods of using the same.
  3. Kole Ryszard (Orange County NC) Dominski Zbigniew (Orange County NC), Antisense oligonucleotides which combat aberrant splicing and methods of using the same.
  4. Kole Ryszard ; Dominski Zbigniew, Antisense oligonucleotides which combat aberrant splicing and methods of using the same.
  5. Kole Ryszard ; Dominski Zbigniew, Antisense oligonucleotides which combat aberrant splicing and methods of using the same.
  6. Gottschalk Peter (Centerville OH) Neckers Douglas C. (Perrysburg OH) Schuster Gary B. (Champaign IL), Cationic dye-triarylmonoalkylorate anion complexes.
  7. Stec Wojciech J. (Lodz PLX) Uznanski Bogdan (Lodz CA PLX) Bergot B. John (Redwood City CA) Hirschbein Bernard L. (San Francisco CA) Fearon Karen L. (Union City CA), Method of synethesizing sulfurized oligonucleotide analogs.

이 특허를 인용한 특허 (66)

  1. Wilton, Stephen Donald; Fletcher, Sue; Adams, Abbie; Meloni, Penny, Antisense molecules and methods for treating pathologies.
  2. Wilton, Stephen Donald; Fletcher, Sue; Adams, Abbie; Meloni, Penny, Antisense molecules and methods for treating pathologies.
  3. Wilton, Stephen Donald; Fletcher, Sue; Adams, Abbie; Meloni, Penny, Antisense molecules and methods for treating pathologies.
  4. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  5. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  6. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  7. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  8. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  9. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  10. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  11. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  12. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  13. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  14. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  15. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  16. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  17. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  18. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  19. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  20. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  21. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  22. Krieg, Arthur M.; Subramanian, Romesh; McSwiggen, James; Lee, Jeannie T., Compositions and methods for modulating ATP2A2 expression.
  23. Krieg, Arthur M.; Subramanian, Romesh; McSwiggen, James; Lee, Jeannie T., Compositions and methods for modulating SMN gene family expression.
  24. Krieg, Arthur M.; Subramanian, Romesh; McSwiggen, James; Lee, Jeannie T., Compositions and methods for modulating UTRN expression.
  25. Krieg, Arthur M.; Subramanian, Romesh; McSwiggen, James; Lee, Jeannie T., Compositions and methods for modulating hemoglobin gene family expression.
  26. Dale, Roderic M. K., Compositions and methods for the treatment of muscle wasting.
  27. Kaye, Edward M., Compositions for treating muscular dystrophy.
  28. Bestwick, Richard K.; Frank, Diane Elizabeth, Exon skipping compositions for treating muscular dystrophy.
  29. van Ommen, Garrit-Jan B.; van Deutekom, Judith C. T.; den Dunnen, Johannes T., Induction of exon skipping in eukaryotic cells.
  30. De Kimpe, Josephus Johannes; Platenburg, Gerard Johannes; Van Deutekom, Judith Christina Theodora; Aartsma-Rus, Annemieke; Van Ommen, Garrit-Jan Boudewijn, Means and methods for counteracting muscle disorders.
  31. Platenburg, Gerard Johannes; de Kimpe, Josephus Johannes; van Deutekom, Judith Christina Theodora; van Ommen, Garrit-Jan Boudewijn; Aartsma-Rus, Annemieke, Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means.
  32. Platenburg, Gerard Johannes; de Kimpe, Josephus Johannes; van Deutekom, Judith Christina Theodora; van Ommen, Garrit-Jan Boudewijn; Aartsma-Rus, Annemieke, Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means.
  33. van Deutekom, Judith Christina Theodora, Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene.
  34. De Kimpe, Josephus Johannes; Platenburg, Gerardus Johannes; Van Deutekom, Judith Christina Theodora; Aartsma-Rus, Annemieke; Van Ommen, Garrit-Jan Boudewijn, Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA.
  35. De Kimpe, Josephus Johannes; Rus, Adriana Marie; Platenburg, Gerard Johannes; Van Deutekom, Judith Christina Theodora; Van Ommen, Garrit-Jan Boudewijn, Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA.
  36. Uhlmann, Eugen; Weber, Markus; Subramanian, Romesh; Rockel, Thomas Dino; Krieg, Arthur M., Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers.
  37. Van Deutekom, Judith Christina Theodora, Modulation of exon recognition in pre-mRNA by interfering RNA structure.
  38. Van Deutekom, Judith Christina Theodora, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  39. Van Deutekom, Judith Christina Theodora; van Ommen, Garrit-Jan B.; Aartsma-Rus, Annemieke; den Dunnen, Johannes Theodorus, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  40. van Deutekom, Judith Christina Theodora, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  41. van Ommen, Garrit-Jan Boudewijn; van Deutekom, Judith Christina Theodora; den Dunnen, Johannes Theodorus; Aartsma-Rus, Annemieke, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  42. Van Ommen, Garrit-Jan Boudewijn; Aartsma-Rus, Annemieke; Van Deutekom, Judith Christina Theodora; De Kimpe, Josephus Johannes; Verbeek, Joseph Stephan; Ylmaz-Elis, Aliye Seda, Molecule for treating an inflammatory disorder.
  43. Kuik-Romeijn, Petra Van; Platenburg, Gerard Johannes, Molecules for targeting compounds to various selected organs, tissues or tumor cells.
  44. Uhlmann, Eugen; Subramanian, Romesh; Krieg, Arthur M., Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers.
  45. Uhlmann, Eugen; Weber, Markus; Subramanian, Romesh; Rockel, Thomas Dino; Krieg, Arthur M., Multimeric oligonucleotides compounds.
  46. Uhlmann, Eugen; Weber, Markus; Subramanian, Romesh; Rockel, Thomas Dino; Krieg, Arthur M., Multimeric oligonucleotides compounds having cleavable linkers.
  47. Uhlmann, Eugen; Weber, Markus; Subramanian, Romesh; Rockel, Thomas Dino; Krieg, Arthur M., Multimetric oligonucleotide compounds.
  48. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  49. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  50. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  51. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  52. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  53. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  54. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  55. Lee, Jeannie T.; Zhao, Jing; Sarma, Kavitha; Borowsky, Mark; Ohsumi, Toshiro Kendrick, Polycomb-associated non-coding RNAS.
  56. Lee, Jeannie T.; Zhao, Jing; Sarma, Kavitha; Borowsky, Mark; Ohsumi, Toshiro Kendrick, Polycomb-associated non-coding RNAs.
  57. Lee, Jeannie T.; Zhao, Jing; Sarma, Kavitha; Borowsky, Mark; Ohsumi, Toshiro Kendrick, Polycomb-associated non-coding RNAs.
  58. Lee, Jeannie T.; Zhao, Jing; Sarma, Kavitha; Borowsky, Mark; Ohsumi, Toshiro Kendrick, Polycomb-associated non-coding RNAs.
  59. Lee, Jeannie T.; Zhao, Jing; Sarma, Kavitha; Borowsky, Mark; Ohsumi, Toshiro Kendrick, Polycomb-associated non-coding RNAs.
  60. Lee, Jeannie T.; Zhao, Jing; Sarma, Kavitha; Borowsky, Mark; Ohsumi, Toshiro Kendrick, Polycomb-associated non-coding RNAs.
  61. de Visser, Peter Christian; van Deutekom, Judith Christina Theodora, RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy.
  62. Iversen, Patrick L.; Hudziak, Robert, Splice-region antisense composition and method.
  63. Iversen, Patrick L.; Hudziak, Robert, Splice-region antisense composition and method.
  64. Iversen, Patrick L.; Hudziak, Robert, Splice-region antisense composition and method.
  65. Iversen, Patrick L.; Hudziak, Robert; Weller, Dwight D., Splice-region antisense composition and method.
  66. De Kimpe, Josephus Johannes; Platenburg, Gerard Johannes; Wansink, Derick Gert, Treatment of genetic disorders associated with DNA repeat instability.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로